Sax Wealth Advisors LLC Boosts Stock Position in Colgate-Palmolive (NYSE:CL)

Sax Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 432.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,764 shares of the company's stock after buying an additional 18,485 shares during the quarter. Sax Wealth Advisors LLC's holdings in Colgate-Palmolive were worth $2,069,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CL. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the third quarter worth about $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $64,000. True Wealth Design LLC increased its position in Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC lifted its stake in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after purchasing an additional 368 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

CL traded up $0.23 during trading on Friday, reaching $88.79. 5,149,874 shares of the company were exchanged, compared to its average volume of 3,679,883. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The company's 50-day moving average is $92.20 and its two-hundred day moving average is $97.74.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's payout ratio is 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.37% of the company's stock.

Wall Street Analyst Weigh In

CL has been the subject of several recent research reports. StockNews.com downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. Finally, UBS Group dropped their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.